Juan Carlos Aragón, OD.
SAN RAMON, Calif.—CooperVision has acquired EnsEyes, the leading supplier of orthokeratology (ortho-k) and scleral contact lenses in Europe’s Nordic region. The company will operate within the CooperVision Specialty EyeCare group, according to an announcement. Headquartered in Kolding, Denmark, EnsEyes has partnered with customers in Denmark, Sweden, Norway, and Finland for the past decade, providing customized lenses and professional education. The acquisition is expected to help accelerate growth of specialty lens adoption across these markets, according to the company.

“We have collaborated with EnsEyes for years, including its use of MyProcornea for lens ordering. Joining CooperVision will give its highly respected team more resources for growth, further build the expertise of our organization, and support eyecare professionals’ soaring enthusiasm for specialty fitting,” said Juan Carlos Aragón, OD, president, CooperVision Specialty EyeCare.

EnsEyes founder—optometrist and former CooperVision executive Esben Nørregaard Sørensen—will remain with the company. Customers should continue to work with their current EnsEyes representatives. Terms of the transaction were not disclosed.

CooperVision Specialty EyeCare develops, manufactures, and provides access to a portfolio of industry-leading soft and custom rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea and presbyopia. The group’s brands include Blanchard, GP Specialists, No7 Contact Lenses, Paragon, Procornea and Soflex.
CooperVision is a division of CooperCompanies (NYSE:COO).